Laura Yecies | Source | CEO & Board Member at Bone Health Technologies, Startup Advisor, Executive Co...
Laura Yecies
Laura Yecies is the CEO of Bone Health Technologies, maker of OsteoBoost, the first effective and safe non-drug treatment for low bone density. Previously she was CEO of SyncThink a, medical diagnostic company, Catch, which she sold to Apple, and SugarSync, which was acquired by J2Global. Earlier she led the Browser division at Netscape, was general manager of Yahoo Mail and VP of Marketing at Check Point. Ms. Yecies has led commercialization and product development programs that have resulted in the use by over 350m customers. She received her MBA from Harvard, has an MSFS from Georgetown and her AB in Government Magna Cum Laude from Dartmouth. She has been profiled in the NYTimes and multiple periodicals and is a prolific speaker and writer on health care and technology.
2012 Stevie Awards for Women in Business — Silver Medal for Female Executive of the Year.
Inc. 500 — Top Female CEO of 2012
U.S. Department of State TechWomen Mentor.
2011 Stevie Awards for Women in Business — Gold Medal for Female Executive of the Year
-
Bone Health Technologies
CEO & Board Member at Bone Health Technologies, Startup Advisor, Executive Coach
-
Start-up to launch saliva-based AI fertility tracker - FemTech World
The US women's health start-up Ovul is launching a saliva-based AI fertility tracker to help women better monitor their ovulation cycles. The tracker uses a well-known methodology known as saliva ferning, or salivary crystallisation. This method, which became recognised as a reliable fertility indicator in the 1950s and 1960s, involves analysing patterns in dried saliva samples to predict ovulation and…
Article
-
“More than half of the devastating, life-altering fragility fractures happen to the 52 million patients with osteopenia who, prior to Osteoboost, had limited treatment options."
